Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML

Exclusion Criteria

• •Presence or history of grade 2 to 4 acute GVHD.
• •No hematological CR of AML at the time of inclusion. CR patients positive with molecular or phenotypic minimal residual disease (MRD) can be included.
• •Pregnancy/breast feeding.
• •Patient considered socially or psychologically unable to comply with the treatment and the required medical follow-up.
• •Concomitant uncontrolled disease and/or organ dysfunction (infection, severe heart, renal, respiratory or hepatic failure…).
• •Primary or secondary graft failure.
• •Previous solid organ allogeneic transplantation.